| | | | | | | | | | |
|
|
|
|
| Dockets Entered On
February 22, 2006
Table of Contents
|
|
|
|
|
|
|
|
|
|
|
| Docket #
|
| Title
|
|
|
|
|
|
|
| 1976N-0052N
|
| OTC Nasal Decongestants
|
|
|
|
|
| 1981N-0022
|
| OTC Weight Control Drug Products for Human Use
|
|
|
|
|
| 1994V-0204
|
| Laser Light Show
|
|
|
|
|
| 1998P-0151
|
| Introduction Of Downed Cattle Into The Food Supply
|
|
|
|
|
| 2004P-0206
|
| No abbreviated new drug application (ANDA) for Fluticasone Propionate Nasel Spray will be approval, unless it contains bioavailability and bioequivalence studies
|
|
|
|
|
| 2004P-0239
|
| Issue a Final and Complete Guidance Document to Determine Bioequivalence (BE) for Nasal Spray Products.
|
|
|
|
|
| 2004P-0348
|
| ANDA for Fluticasone Propionate Nasal Spray, 50 mcg
|
|
|
|
|
| 2004P-0523
|
| Generic fluticasone propionate nasal spray products meet the same high standards of quality as GSK's brand-name product Flonase
|
|
|
|
|
| 2005N-0354
|
| Consumer-Directed Promotion of Regulated Medical Products; Part 15 Public Hearing
|
|
|
|
|
| 2005N-0425
|
| Agency Information Collection Activities; Proposed Collection; Comment Request; General Administrative Procedures: Citizen Petitions; Petition for Reconsideration or Stay of Action; Advisory Opinions
|
|
|
|
|
|
| 2005N-0479
|
| International Drug Scheduling; Convention on Psychotropic Substances; Single Convention on Narcotic Drugs; Butorphanol; Delta-9-tetrahydrocannabinol (Dronabinol); Gamma-Hydroxybutyric Acid; Ketamine;
|
|
|
|
|
|
|
|
|
| 2005P-0377
|
| Petition to Rescind the "Generally Recognized as Safe" or GRAS Status for Aluminum Based Food Additives
|
|
|
|
|
| 2005P-0411
|
| Seeking FDA Actions to Counter Flagrant Violations of the Law by Pharmacies Compounding Bio-Identical Hormone Replacement Therapy Drugs
|
|
|
|
|
| 2006F-0059
|
| Safe Use of Polydextrose as a Bulking Agent, Formulation Aid, Humectant and Texturizer in All Foods, except Meat and Poultry (FAP 6A4763)
|
|
|
|
|
| 2006N-0038
|
| Agency Information Collection Activities; Proposed Collection; Comment Request; Irradiation in the Production, Processing, and Handling of Food
|
|
|
|
|
| 2006P-0084
|
| ANDA Suitability for 1.25 mg, 2.50 mg, 5 mg, and 10 mg Ramipril Tablets
|
|
|
|
|
| 1976N-0052N
|
| OTC Nasal Decongestants
|
|
|
|
|
| C 244
|
| E. Greisch
|
| Vol #:
|
| 77
|
|
|
|
|
| 1981N-0022
|
| OTC Weight Control Drug Products for Human Use
|
|
|
|
|
| C 122
|
| E. Greisch
|
| Vol #:
|
| 98
|
|
|
|
|
| 1994V-0204
|
| Laser Light Show
|
|
|
|
|
| EXP 2
|
| Sam's Town Hotel & Gambling Hall
|
| Vol #:
|
| 1
|
|
| |
|
| 1998P-0151
|
| Introduction Of Downed Cattle Into The Food Supply
|
|
|
|
|
| C 7522
|
| Eligible
|
| Vol #:
|
| 319
|
|
|
|
|
| 2004P-0206
|
| No abbreviated new drug application (ANDA) for Fluticasone Propionate Nasel Spray will be approval, unless it contains bioavailability and bioequivalence studies
|
|
|
|
|
| PDN 1
|
| FDA/OPP to McGuire Woods, GlaxoSmithKline, Frommer Lawrence & Haug LLP
|
| Vol #:
|
| 1
|
|
|
|
|
| 2004P-0239
|
| Issue a Final and Complete Guidance Document to Determine Bioequivalence (BE) for Nasal Spray Products.
|
|
|
|
|
| PDN 1
|
| FDA/OPP to McGuire Woods LLP, GlaxoSmithKline, Frommer Lawrence & Haug LLP
|
| Vol #:
|
| 1
|
|
|
|
|
| 2004P-0348
|
| ANDA for Fluticasone Propionate Nasal Spray, 50 mcg
|
|
|
|
|
| PDN 1
|
| FDA/OPP to McGuire Woods LLP, GlaxoSmithKline, Frommer Lawrence & Haug LLP
|
| Vol #:
|
| 1
|
|
|
|
|
| 2004P-0523
| Generic fluticasone propionate nasal spray products meet the same high standards of quality as GSK's brand-name product Flonase
|
